Park, J.H.; Tran, P.T.; Ko, H.L.; Mun, S.; Jang, S.C.; Moon, D.H.; Han, J.; Kim, J.; Kim, G.; Choi, H.;
et al. Design, Synthesis, and Biological Evaluation of 5′,7-Disubstituted 7-Deaza-adenosine Analogues as Irreversible Pan-FGFR Inhibitors. Pharmaceuticals 2025, 18, 1745.
https://doi.org/10.3390/ph18111745
AMA Style
Park JH, Tran PT, Ko HL, Mun S, Jang SC, Moon DH, Han J, Kim J, Kim G, Choi H,
et al. Design, Synthesis, and Biological Evaluation of 5′,7-Disubstituted 7-Deaza-adenosine Analogues as Irreversible Pan-FGFR Inhibitors. Pharmaceuticals. 2025; 18(11):1745.
https://doi.org/10.3390/ph18111745
Chicago/Turabian Style
Park, Jung Hoon, Phuong Thao Tran, Hye Lin Ko, Seonghee Mun, Sung Chul Jang, Dong Hyun Moon, Jaeho Han, Jieun Kim, Gibae Kim, Hongseok Choi,
and et al. 2025. "Design, Synthesis, and Biological Evaluation of 5′,7-Disubstituted 7-Deaza-adenosine Analogues as Irreversible Pan-FGFR Inhibitors" Pharmaceuticals 18, no. 11: 1745.
https://doi.org/10.3390/ph18111745
APA Style
Park, J. H., Tran, P. T., Ko, H. L., Mun, S., Jang, S. C., Moon, D. H., Han, J., Kim, J., Kim, G., Choi, H., Kim, S. W., Kim, M., Lee, S. K., Han, B. W., Kang, K. W., & Jeong, L. S.
(2025). Design, Synthesis, and Biological Evaluation of 5′,7-Disubstituted 7-Deaza-adenosine Analogues as Irreversible Pan-FGFR Inhibitors. Pharmaceuticals, 18(11), 1745.
https://doi.org/10.3390/ph18111745
